Expand KYMR Menu
KYMR MENU

KYMR Stock Posts


Unusual Option Volume

KYMR Kymera Therapeutics108.38-8.08 (-6.9%)

Kymera Therapeutics trades 2,580 contracts.
Unusual Option Volume

KYMR Kymera Therapeutics121.50+21.63 (+21.7%)

KYMR #KymeraTherapeutics stock declines -3.8% in after hours trading. See the latest news.

After Hours Decliner

KYMR Kymera Therapeutics94.30+27.68+41.6%

After Hours:90.70-3.60 (-3.8%)

Kymera Therapeutics Announces Proposed Public Offering

Globe NewswireMon, 8-Dec 4:01 PM

KYMR #KymeraTherapeutics stock declines -3.8% in after hours trading. See the latest news.

After Hours Decliner

KYMR Kymera Therapeutics94.30+27.68+41.6%

After Hours:90.70-3.60 (-3.8%)

Kymera Therapeutics Announces Proposed Public Offering

Globe NewswireMon, 8-Dec 4:01 PM

Unusual Option Volume

KYMR Kymera Therapeutics94.75+28.13 (+42.2%)

Kymera Therapeutics trades 2,215 contracts. The company has the following event: KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results Video Conference Call and Webcast on Dec 8, 2025. News: Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis
KYMR #KymeraTherapeutics stock increases 5.1% after hours.

After Hours Gainer

KYMR Kymera Therapeutics66.62+0.39+0.6%

After Hours:70.00+3.38 (+5.1%)

Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025

Globe NewswireFri, 5-Dec 4:01 PM

Market Data Delayed 15 Minutes